Verona Pharma Plc

NASDAQ: VRNA
$37.86
-$0.99 (-2.5%)
Closing Price on November 21, 2024

VRNA Stock Chart and Intraday Price

VRNA Stock Data

Asset Type Stock
Exchange NASDAQ
Currency USD
Country USA
Sector LIFE SCIENCES
Industry PHARMACEUTICAL PREPARATIONS
Address 3 MORE LONDON RIVERSIDE, LONDON, GB
Fiscal Year End December
Latest Quarter 9/30/2023
Market Cap 1,454.11M USD
Shares Outstanding 79,940,000
Verona Pharma Plc is a London-based biopharmaceutical company focused on creating treatments for respiratory diseases lacking adequate therapies. Its leading product, ensifentrine, is a novel compound with dual action as a bronchodilator and anti-inflammatory agent, currently in Phase 3 trials for conditions like chronic obstructive pulmonary disease, asthma, and cystic fibrosis. Verona Pharma is exploring ensifentrine in various forms, including nebulizer, dry powder inhaler, and pressurized metered-dose inhaler, aiming to meet critical healthcare needs.

VRNA Articles

Tuesday's Top Analyst Upgrades and Downgrades: Apple, Conagra, CSX, Deere, DraftKings, Foot Locker, KeyCorp, Nike, Salesforce and More
Tuesday's top analyst upgrades and downgrades included Apple, Azul, Conagra Brands, Corteva, CSX, Deere, DraftKings, Foot Locker, Intuit, KeyCorp, Nike, Salesforce, Take-Two Interactive Software,...
Lee Jackson
Published:

Tuesday's Top Analyst Upgrades and Downgrades: Adobe, Huntsman, Kraft Heinz, NCR, Peloton, Take-Two and Many More
Tuesday's top analyst upgrades and downgrades included Adobe, Cheniere Energy, CNX Resources, Edwards Lifesciences, EOG Resources, Huntsman, Kraft Heinz, NCR, Peloton Interactive, PulteGroup,...
Lee Jackson
Published:

What the Fed Is Setting Up for Wednesday: Analysts Upgrade or Downgrade ConocoPhillips, Netflix and More
Monday's additional top analyst upgrades and downgrades were on Array Technologies, ConocoPhillips, EQT, KB Home, Lennar, NetApp, Netflix and more.
Chris Lange
Published:

Monday's Top Analyst Upgrades and Downgrades: Affirm, AstraZeneca, Broadcom, Dell, Dollar General, Marvell, Tesla, Union Pacific, Workday and More
Monday’s top analyst upgrades and downgrades included Affirm, AstraZeneca, Broadcom, Centene, Dell Technologies, Dollar General, Marvell Technology, Medical Properties Trust, Tesla, Ulta Beauty,...
Lee Jackson
Published:
Last Updated:

Fed Sets Up More Rate Hikes: Analysts Upgrade or Downgrade Gap, Zoom Video and More
Friday's additional top analyst upgrades and downgrades were on Burlington Stores, Forge Global, Gap, Ulta Beauty, Zoom Video Communications and more.
Chris Lange
Published:
Last Updated:

Top Analyst Upgrades and Downgrades: Albermarle, Apple, ConEd, Etsy, GoHealth, Hecla, NortonLifeLock, Pinterest, Switch, T-Mobile and More
Monday's top analyst upgrades and downgrades included Albermarle, Apple, Consolidated Edison, Etsy, GoHealth, Hecla Mining, NortonLifeLock, Pinterest, Switch and T-Mobile.
Jon C. Ogg
Published: